186 related articles for article (PubMed ID: 28495592)
1. miR-21 Promotes Fibrogenesis in Peritoneal Dialysis.
Lopez-Anton M; Lambie M; Lopez-Cabrera M; Schmitt CP; Ruiz-Carpio V; Bartosova M; Schaefer B; Davies S; Stone T; Jenkins R; Taylor PR; Topley N; Bowen T; Fraser D
Am J Pathol; 2017 Jul; 187(7):1537-1550. PubMed ID: 28495592
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-302c modulates peritoneal dialysis-associated fibrosis by targeting connective tissue growth factor.
Li X; Liu H; Sun L; Zhou X; Yuan X; Chen Y; Liu F; Liu Y; Xiao L
J Cell Mol Med; 2019 Apr; 23(4):2372-2383. PubMed ID: 30693641
[TBL] [Abstract][Full Text] [Related]
3. MiR-200a negatively regulates TGF-β
Guo R; Hao G; Bao Y; Xiao J; Zhan X; Shi X; Luo L; Zhou J; Chen Q; Wei X
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1087-F1095. PubMed ID: 29357421
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-145 promotes the epithelial-mesenchymal transition in peritoneal dialysis-associated fibrosis by suppressing fibroblast growth factor 10.
Wu J; Huang Q; Li P; Wang Y; Zheng C; Lei X; Li S; Gong W; Yin B; Luo C; Xiao J; Zhou W; Xu Z; Chen Y; Peng F; Long H
J Biol Chem; 2019 Oct; 294(41):15052-15067. PubMed ID: 31431501
[TBL] [Abstract][Full Text] [Related]
6. Impact of a low-glucose peritoneal dialysis regimen on fibrosis and inflammation biomarkers.
Yung S; Lui SL; Ng CK; Yim A; Ma MK; Lo KY; Chow CC; Chu KH; Chak WL; Lam MF; Yung CY; Yip TP; Wong S; Tang CS; Ng FS; Chan TM
Perit Dial Int; 2015; 35(2):147-58. PubMed ID: 25904773
[TBL] [Abstract][Full Text] [Related]
7. Peritoneal dialysis effluent miR-21 and miR-589 levels correlate with longitudinal change in peritoneal transport characteristics.
Szeto CC; Chow KM; Kwan BC; Cheng PM; Luk CC; Ng JK; Law MC; Leung CB; Li PK
Clin Chim Acta; 2017 Jan; 464():106-112. PubMed ID: 27867039
[TBL] [Abstract][Full Text] [Related]
8. miR-15a-5p suppresses inflammation and fibrosis of peritoneal mesothelial cells induced by peritoneal dialysis via targeting VEGFA.
Shang J; He Q; Chen Y; Yu D; Sun L; Cheng G; Liu D; Xiao J; Zhao Z
J Cell Physiol; 2019 Jun; 234(6):9746-9755. PubMed ID: 30362573
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of HDAC6 in clinical peritoneal dialysis patients and its pathogenic role on peritoneal angiogenesis.
Shi Y; Ni J; Tao M; Ma X; Wang Y; Zang X; Hu Y; Qiu A; Zhuang S; Liu N
Ren Fail; 2020 Nov; 42(1):890-901. PubMed ID: 32862739
[TBL] [Abstract][Full Text] [Related]
10. miR-30a negatively regulates TGF-β1-induced epithelial-mesenchymal transition and peritoneal fibrosis by targeting Snai1.
Zhou Q; Yang M; Lan H; Yu X
Am J Pathol; 2013 Sep; 183(3):808-19. PubMed ID: 23831330
[TBL] [Abstract][Full Text] [Related]
11. Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate.
Mizutani M; Ito Y; Mizuno M; Nishimura H; Suzuki Y; Hattori R; Matsukawa Y; Imai M; Oliver N; Goldschmeding R; Aten J; Krediet RT; Yuzawa Y; Matsuo S
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F721-33. PubMed ID: 20015945
[TBL] [Abstract][Full Text] [Related]
12. High peritoneal permeability is not associated with higher mortality or technique failure in patients on automated peritoneal dialysis.
Yang X; Fang W; Bargman JM; Oreopoulos DG
Perit Dial Int; 2008; 28(1):82-92. PubMed ID: 18178952
[TBL] [Abstract][Full Text] [Related]
13. Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis.
Yokoi H; Kasahara M; Mori K; Ogawa Y; Kuwabara T; Imamaki H; Kawanishi T; Koga K; Ishii A; Kato Y; Mori KP; Toda N; Ohno S; Muramatsu H; Muramatsu T; Sugawara A; Mukoyama M; Nakao K
Kidney Int; 2012 Jan; 81(2):160-9. PubMed ID: 21881556
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions.
Parikova A; Zweers MM; Struijk DG; Krediet RT
Adv Perit Dial; 2003; 19():186-90. PubMed ID: 14763059
[TBL] [Abstract][Full Text] [Related]
16. Patients with encapsulating peritoneal sclerosis have increased peritoneal expression of connective tissue growth factor (CCN2), transforming growth factor-β1, and vascular endothelial growth factor.
Abrahams AC; Habib SM; Dendooven A; Riser BL; van der Veer JW; Toorop RJ; Betjes MG; Verhaar MC; Watson CJ; Nguyen TQ; Boer WH
PLoS One; 2014; 9(11):e112050. PubMed ID: 25384022
[TBL] [Abstract][Full Text] [Related]
17. Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.
Shi Y; Tao M; Wang Y; Zang X; Ma X; Qiu A; Zhuang S; Liu N
J Pathol; 2020 Jan; 250(1):79-94. PubMed ID: 31579944
[TBL] [Abstract][Full Text] [Related]
18. miR-15a-5p suppresses peritoneal fibrosis induced by peritoneal dialysis via targeting VEGF in rats.
He Q; Wen L; Wang L; Zhang Y; Yu W; Zhang F; Zhang W; Xiao J; Wen X; Zhao Z
Ren Fail; 2020 Nov; 42(1):932-943. PubMed ID: 32909490
[TBL] [Abstract][Full Text] [Related]
19. The peritoneal-renal syndrome.
Nessim SJ; Bargman JM
Nat Rev Nephrol; 2013 May; 9(5):302-6. PubMed ID: 23507827
[TBL] [Abstract][Full Text] [Related]
20. Icodextrin and intraperitoneal inflammation.
Moriishi M; Kawanishi H
Perit Dial Int; 2008 Jun; 28 Suppl 3():S96-S100. PubMed ID: 18552274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
